Concepedia

Publication | Open Access

Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer

DOIFull Paper Access

48

Citations

32

References

2012

Year

Guan Wang, Jing He, Jianyun Zhao, Wenting Yun, Chengzhi Xie, Jeffrey W. Taub, Asfar S. Azmi, Ramzi M. Mohammad, Yan Dong, Wei Kong,
PLoS ONE

Abstract

Our results suggest that classes I and II HDACs are potential therapeutic targets for treating pancreatic cancer. Accordingly, treating pancreatic cancer with pan-HDACIs may be more beneficial than class- or isoform-selective inhibitors.

References

YearCitations

Page 1